# US 2016/0354728 A1 · Hollow- fiber membrane blood purification device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354728 A1
- Document ID: US20160354728A1
- Status: Published application
- Kind: A1
- Application number: 15/104,072
- Filed: 2014-12-16
- Published: 2016-12-08
- Earliest claimed: 2013-12-16
- Assignees: Asahi Kasei Medical Co., Ltd.
- Applicants: Asahi Kasei Medical Co., Ltd.
- Inventors: Ryoko HORI; Yosuke HATA; Junya KAWAKAMI
- Web page: https://patentgrep.com/patent/US20160354728A1

## CPC

- B01D 69/144: {containing embedded or bound biomolecules}
- A61M 1/1621: {Constructional aspects thereof (semi-permeable membranes for separation processes characterised by their properties B01D69/00; semi permeable membranes characterised by their material B01D71/00)}
- A61P 7/08: Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04)
- B01D 63/02: Hollow fibre modules
- B01D 67/0088: {Physical treatment with compounds, e.g. swelling, coating or impregnation}
- B01D 69/08: Hollow fibre membranes (manufacture of hollow fibres D01D5/24, D01F1/08)
- B01D 71/68: Polysulfones; Polyethersulfones
- C08L 33/12: Homopolymers or copolymers of methyl methacrylate
- C08L 81/06: Polysulfones; Polyethersulfones
- A61M 1/16: with membranes
- B01D 63/023: {Encapsulating materials}
- B01D 2323/081: Heating
- B01D 2323/12: Specific ratios of components used
- B01D 2323/2187: Polyvinylpyrolidone
- B01D 2323/22: Specific non-solvents or non-solvent system
- B01D 2325/06: Surface irregularities
- C08L 2201/08: Stabilised against heat, light or radiation or oxydation
- C08L 2203/02: for biomedical use
- C08L 2203/12: used for fibers
- C08L 2205/025: containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Disclosed is a hollow-fiber membrane blood purification device having an improved antioxidant performance, good water permeation performance and blood compatibility performance, and economic rationality. The present invention provides a hollow-fiber membrane blood purification device including hollow-fiber membranes filled in a vessel, in which the hollow-fiber membranes contain a hydrophobic polymer, a hydrophilic polymer and a fat-soluble vitamin, when a hollow-fiber membrane bundle is divided into five sections in a lengthwise direction and divided sections positioned in endmost portions are defined as body end portions, an amount of the fat-soluble vitamin present in at least one of the body end portions is the largest among amounts of the fat-soluble vitamin present respectively in all the divided sections, and an amount of the fat-soluble vitamin per m2 of a hollow-fiber membrane inner surface of the at least one body end portion is 20 mg/m2 or more and 300 mg/m2 or less.

## Claims

### Claim at position 1

1-8. (canceled)

### Claim 9

A hollow-fiber membrane blood purification device comprising hollow-fiber membranes filled in a vessel,
wherein the hollow-fiber membranes contain a hydrophobic polymer, a hydrophilic polymer and a fat-soluble vitamin,
when a hollow-fiber membrane bundle is divided into five sections in a lengthwise direction and divided sections positioned in endmost portions are defined as body end portions, an amount of the fat-soluble vitamin present in at least one of the body end portions is the largest among amounts of the fat-soluble vitamin present respectively in all the divided sections, and an amount of the fat-soluble vitamin per m2 of a hollow-fiber membrane inner surface of the at least one body end portion is 20 mg/m2 or more and 300 mg/m2 or less.

### Claim 10 (depends on 9)

The hollow-fiber membrane blood purification device according to claim 9, wherein when an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the body end portion where the amount of the fat-soluble vitamin is the largest is defined as A (mg/m2) and an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in a divided section where the amount of the fat-soluble vitamin is the smallest among the other divided sections is defined as B (mg/m2), a ratio (A/B) between the amounts A and B is 1.1 or more and 10 or less.

### Claim 11 (depends on 10)

The hollow-fiber membrane blood purification device according to claim 10, wherein the ratio (A/B) between the amounts A and B is 1.3 or more and 10 or less.

### Claim 12 (depends on 9)

The hollow-fiber membrane blood purification device according to claim 9, wherein when within an inner circle having a ½ radius of the hollow-fiber membrane bundle is defined as a center portion and a portion not included in the center portion is defined as an outside portion, an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the center portion is larger than an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the outside portion.

### Claim 13 (depends on 10)

The hollow-fiber membrane blood purification device according to claim 10, wherein when within an inner circle having a ½ radius of the hollow-fiber membrane bundle is defined as a center portion and a portion not included in the center portion is defined as an outside portion, an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the center portion is larger than an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the outside portion.

### Claim 14 (depends on 11)

The hollow-fiber membrane blood purification device according to claim 11, wherein when within an inner circle having a ½ radius of the hollow-fiber membrane bundle is defined as a center portion and a portion not included in the center portion is defined as an outside portion, an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the center portion is larger than an amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the outside portion.

### Claim 15 (depends on 12)

The hollow-fiber membrane blood purification device according to claim 12, wherein when the amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the center portion is defined as C (mg/m2) and the amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the outside portion is defined as D (mg/m2), a ratio (C/D) between the amounts C and D is 1.1 or more and 50 or less.

### Claim 16 (depends on 13)

The hollow-fiber membrane blood purification device according to claim 13, wherein when the amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the center portion is defined as C (mg/m2) and the amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the outside portion is defined as D (mg/m2), a ratio (C/D) between the amounts C and D is 1.1 or more and 50 or less.

### Claim 17 (depends on 14)

The hollow-fiber membrane blood purification device according to claim 14, wherein when the amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the center portion is defined as C (mg/m2) and the amount of the fat-soluble vitamin per m2 of the hollow-fiber membrane inner surface present in the outside portion is defined as D (mg/m2), a ratio (C/D) between the amounts C and D is 1.1 or more and 50 or less.

### Claim 18 (depends on 9)

The hollow-fiber membrane blood purification device according to claim 9, wherein the hydrophobic polymer has a solubility parameter δ (cal/cm3)1/2 of 13.0 or less.

### Claim 19 (depends on 9)

The hollow-fiber membrane blood purification device according to claim 9, wherein the hydrophobic polymer is any one selected from the group consisting of polysulfones, polyethersulfones and cellulose acetates.

### Claim 20 (depends on 9)

The hollow-fiber membrane blood purification device according to claim 9, wherein the hydrophilic polymer is polyvinylpyrrolidone.

### Claim 21 (depends on 15)

The hollow-fiber membrane blood purification device according to claim 15, wherein the hydrophilic polymer is polyvinylpyrrolidone.

### Claim 22 (depends on 16)

The hollow-fiber membrane blood purification device according to claim 16, wherein the hydrophilic polymer is polyvinylpyrrolidone.

### Claim 23 (depends on 17)

The hollow-fiber membrane blood purification device according to claim 17, wherein the hydrophilic polymer is polyvinylpyrrolidone.

### Claim 24 (depends on 18)

The hollow-fiber membrane blood purification device according to claim 18, wherein the hydrophilic polymer is polyvinylpyrrolidone.

### Claim 25 (depends on 19)

The hollow-fiber membrane blood purification device according to claim 19, wherein the hydrophilic polymer is polyvinylpyrrolidone.
